Kura Oncology Q2 Revenue Up 57% QoQ; Cash Runway Extended to Q4 2027
KURA sits 82% above its 52-week low of $5.52.
Summary
Kura Oncology reported Q2 2026 net product revenue of $9.1 million, up 57% sequentially, and extended its cash runway guidance into Q4 2027 with $519 million in cash and investments.
Key Events · Earnings and Guidance · KURA
-
KOMZIFTI Revenue Accelerates
Q2 2026 net product revenue was $9.1 million, up 57% from Q1 2026, driven by accelerating uptake in relapsed/refractory NPM1-mutated AML.
-
Cash Runway Extended
Cash, cash equivalents and short-term investments totaled $519.0 million as of June 30, 2026, sufficient to fund operations into Q4 2027.
-
Kyowa Kirin Milestone Potential
Kura has received or expects $597.1 million under the Kyowa License Agreement, with up to $1.491 billion in total upfront and milestone payments possible.
-
Net Loss Widens
Q2 2026 net loss was $68.3 million ($0.77 per share), compared to $66.1 million in Q2 2025, reflecting higher SG&A and R&D investment.
Analysis · KURA · Life Sciences
Kura Oncology's Q2 2026 10-Q shows accelerating KOMZIFTI launch momentum with net product revenue of $9.1 million, up 57% quarter-over-quarter. Total revenue reached $20.9 million, including $11.8 million in collaboration revenue from Kyowa Kirin. The company holds $519.0 million in cash and investments, which management states is sufficient to fund operations into the fourth quarter of 2027 — a meaningful extension of runway that reduces near-term financing risk. Net loss widened to $68.3 million for the quarter, driven by higher SG&A and R&D spending to support the commercial launch and clinical programs. The filing also discloses modifications to 10b5-1 trading plans by three senior officers, a routine governance item.
At the time of this filing, KURA was trading at $10.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $882.4M. The 52-week trading range was $5.52 to $12.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.